HCL Pharma SRL
HCL Pharma reported total assets of 502,215 € at the end of the 2025 financial year (annual accounts filed with the NBB on 29 Jul 2026).
The score of HCL Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -44 % Total assets 0 %
Accounts of the company itself (not consolidated).
The full file covers 9 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
HCL Pharma's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 36,408 € | ||||
| Equity | 57,108 € | ||||
| Cash | 44,170 € | ||||
| EBITDA | 80,657 € | ||||
| Total assets | 502,215 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 29 Jul 2026
- Year ended 31 Dec 2024filed on 17 Jul 2025
- Year ended 31 Dec 2023filed on 30 Aug 2024
- Year ended 31 Dec 2022filed on 13 Jul 2023
- Year ended 31 Dec 2021filed on 05 Jul 2022
HCL Pharma's financial analysis
- Solvency11.4%sector median: 41.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of HCL Pharma
HCL Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0649.663.933
- VAT number
- BE0649663933
- Peppol
- Registered · 0208:0649663933 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 06 Mar 2016
- Registered office
- 5650 Walcourt
- Latest accounts
- 2025 · filed on 29 Jul 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
HCL Pharma (SRL) has been based in Walcourt since 2016, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 36,408 € and equity of 57,108 €; its revenue is not published. Its solvency stands at 11.4%, below the median of its sector (41.5%).
Companies similar to HCL Pharma
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie Depoitte Retail sale of pharmaceutical products Grâce-Hollogne · balance sheet 501,536 €
- Mecla Retail sale of pharmaceutical products Dour · balance sheet 502,903 €
- Pharmaproducts Retail sale of pharmaceutical products Heusden-Zolder · balance sheet 501,031 €
- Apotheek Caroline Jugnon Retail sale of pharmaceutical products Antwerp · balance sheet 503,505 €
- Verzele Pharma Retail sale of pharmaceutical products Oudenaarde · balance sheet 500,597 €
- Apoteek Diependale Retail sale of pharmaceutical products Oudenaarde · balance sheet 504,088 €
- Zwitserse Apotheek Retail sale of pharmaceutical products Wijnegem · balance sheet 498,014 €
- Secundum Artem Retail sale of pharmaceutical products Etterbeek · balance sheet 496,587 €
Frequently asked questions about HCL Pharma
What is the revenue of HCL Pharma?
HCL Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of HCL Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0649663933 for HCL Pharma, if the company is VAT-registered. Its company number (CBE) is 0649.663.933.
Where is the registered office of HCL Pharma?
According to the CBE register, the registered office of HCL Pharma is in 5650 Walcourt.
What is the equity of HCL Pharma?
At the close of the 2025 financial year, the equity of HCL Pharma amounts to 57,108 €, a solvency of 11.4% of total assets.
Who manages HCL Pharma?
The register lists 1 active mandates at HCL Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of HCL Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →